Mansoor Raza Mirza is Director at Karyopharm Therapeutics Inc. (KPTI). They have made 26 open-market trades across 2 companies since 2014, most recently 2026-07-10.
CIK 0001588389
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SERA | 80,166 | $164K |
| ACRV | 38,817 | $64K |
| KPTI | 5,000 | $2K |
| Total | $229K |
Shares reported on the most recent Form 4, priced at the 2026-07-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SERA | SELL | 2025-12-05 | 2025-12-05 | $3.05 | $891 | +17.7% | +0.3% | -34.4% |
| SERA | SELL | 2025-11-05 | 2025-11-06 | $3.04 | $672 | +16.9% | +14.2% | -1.5% |
| SERA | SELL | 2025-10-06 | 2025-10-06 | $3.16 | $717 | +2.1% | -5.5% | -6.4% |
| SERA | SELL | 2025-09-05 | 2025-09-05 | $3.35 | $744 | -3.9% | -2.4% | -10.8% |
| SERA | SELL | 2025-08-05 | 2025-08-05 | $2.50 | $563 | -7.4% | +40.3% | +31.7% |
| SERA | SELL | 2025-07-07 | 2025-07-08 | $2.36 | $552 | +8.1% | -3.7% | +20.7% |
| SERA | SELL | 2025-06-06 | 2025-06-06 | $1.58 | $169 | +21.3% | +56.1% | +120.0% |
| SERA | SELL | 2025-05-08 | 2025-05-09 | $2.44 | $259 | -16.5% | -34.8% | +13.0% |
| SERA | SELL | 2025-04-07 | 2025-04-08 | $3.35 | $358 | +0.6% | -37.1% | -28.2% |
| SERA | SELL | 2025-03-06 | 2025-03-07 | $4.16 | $412 | -1.2% | -19.1% | -61.8% |
| SERA | SELL | 2025-02-12 | 2025-02-14 | $4.58 | $463 | +1.7% | +2.7% | -40.8% |
| SERA | SELL | 2025-01-06 | 2025-01-07 | $7.69 | $769 | -16.5% | -40.8% | -57.4% |
| SERA | SELL | 2024-12-06 | 2024-12-09 | $7.12 | $662 | +5.3% | +7.8% | -46.4% |
| SERA | SELL | 2024-11-11 | 2024-11-12 | $7.32 | $695 | -11.1% | +16.0% | -39.5% |
| SERA | SELL | 2024-10-07 | 2024-10-07 | $7.15 | $686 | +11.7% | +26.7% | +11.6% |
| SERA | SELL | 2024-09-06 | 2024-09-09 | $7.16 | $687 | +8.0% | -10.9% | +6.2% |
| SERA | SELL | 2024-08-07 | 2024-08-08 | $7.42 | $749 | -3.7% | -0.3% | +19.4% |
| KPTI | SELL | 2020-12-18 | 2020-12-22 | $18.00 | $90K | +3.0% | -12.3% | -31.3% |
| KPTI | SELL | 2020-12-07 | 2020-12-08 | $16.08 | $241K | +3.5% | +8.1% | -30.4% |
| KPTI | SELL | 2020-03-02 | 2020-03-04 | $23.50 | $118K | -36.5% | -31.5% | -30.5% |
| KPTI | SELL · 10b5-1 | 2020-01-09 | 2020-01-13 | $20.00 | $41K | -4.9% | -3.0% | +16.3% |
| KPTI | SELL | 2019-12-27 | 2019-12-31 | $20.00 | $59K | -10.6% | -16.2% | +3.8% |
| KPTI | SELL | 2019-12-18 | 2019-12-20 | $17.18 | $331K | -0.6% | -4.3% | +4.4% |
| KPTI | SELL | 2019-12-09 | 2019-12-11 | $17.02 | $267K | +14.3% | +9.5% | +37.7% |
| KPTI | SELL | 2018-08-30 | 2018-09-04 | $21.00 | $53K | -9.6% | -28.2% | -47.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.